Skip to main content

Prelude Therapeutics Inc

PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001678660

No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Prelude Therapeutics Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of PRLD: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders6057−3
Shares32.5M34.5M+1.91M (+5.9%)
Value$1.41B$986.6M−$423.5M (−30.0%)

New holders (9)

Institutions that held Prelude Therapeutics Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to PRLD in Q2 2021
InstitutionSharesValue% of portfolio
Logos Global Management LP400,000$11.5M0.98%
Swiss National Bank20,500$587.0K0.00%
Susquehanna International Group, LLP17,153$491.0K0.00%
Voloridge Investment Management, LLC15,319$439.0K0.00%
Commonwealth Equity Services, LLC10,927$312.0K0.00%
Two Sigma Investments, LP10,116$290.0K0.00%
Virtus ETF Advisers LLC6,622$190.0K0.08%
Dark Forest Capital Management LP155$4.00K0.00%
Parallel Advisors, LLC32$1.00K0.00%

Sold out (12)

Institutions that held Prelude Therapeutics Inc at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of PRLD in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Marshall Wace, LLP29,315$1.27M
Citadel Advisors LLC19,496$845.0K
California Public Employees Retirement System17,638$764.0K
Ensign Peak Advisors, Inc17,498$758.0K
Bank Julius Baer & Co. Ltd, Zurich17,312$750.0K
D. E. Shaw & Co., Inc.12,546$544.0K
Manufacturers Life Insurance Company, The5,516$239.0K
Parametric Portfolio Associates LLC5,178$224.0K
Parkwood LLC5,037$218.0K
IFP Advisors, Inc1,194$52.0K
Pacer Advisors, Inc.1,126$49.0K
Bank of Montreal300$11.0K